Background: The source of glutamine for renal ammonium production is ultimately dietary protein in the fed state and body proteins in fasting. Objective: Our objective was to determine if less NH+4 would be excreted by fasted dogs with chronic metabolic acidosis resulting in conservation of lean body mass. Methods: Acid-loaded fed and fasted dogs were given 10 mmol NH4Cl/kg for 5 days; the fasted group had food withheld on days 4 and 5. Results: The renal production of NH+4 was not significantly different in both acid-loaded groups, yet the rate of NH+4 excretion was significantly lower in the fasted dogs (8 vs. 21 mmol NH+4/mmol creatinine). The urine pH was significantly higher (6.0 versus 5.5) while titratable acid and the urine flow rate were significantly lower in these fasted dogs. Despite nearly equal urine flow rates and Na+ excretion rates after an infusion of saline, the fasted dogs failed to increase the rate of excretion of NH+4 to rates seen in the fed group. Conclusions: The lower rate of excretion of NH+4 in fasted, acidotic dogs appeared to be due to a lower distal H+ secretion. This may help preserve lean body mass during fasting.

Keywords:
Glutamine, Chronic metabolic acidosis, Ammonium, Lean body mass, Fasted dogs
1.
Nagami GT: Renal ammonia production and excretion; in Seldin DW, Giebisch G (eds): The Kidney: Physiology and Pathophysiology. Philadelphia, Lippincott Williams & Wilkins, 2000, vol 2, pp 1995–2014.
2.
Halperin ML, Ethier JH, Kamel KS: Ammonium excretion in chronic metabolic acidosis: Risks and benefits. Am J Kidney Dis 1989;9:265–268.
3.
Knepper MA, Packer R, Good DW: Ammonium transport in the kidney. Physiol Rev 1989;69:179–249.
4.
Halperin ML, Vinay P, Gougoux A, Pichette C, Jungas RL: Regulation of the maximum rate of renal ammoniagenesis in the acidotic dog. Am J Physiol 1985;248:F607–F615.
5.
Van Slyke DD, Sendroy JJ, Hastings AB, Neill JM: Studies of gas and electrolyte equilibria in blood. X. The solubility of carbon dioxide at 38°C in water, salt solution, serum and blood cells. J Biol Chem 1928;78:765–799.
6.
Hastings AB, Sendroy JJ: The effect of variation in ionic strength on the apparent first and second dissociation constants of carbonic acid. J Biol Chem 1925;65:445–455.
7.
Wolf A: Total renal blood flow at any urine flow rate or extraction ratio. Am J Physiol 1941;133:496–497.
8.
Halperin ML, Jungas RL, Pichette C, Goldstein MB: A quantitative analysis of renal ammoniagenesis and energy balance: A theoretical approach. Can J Physiol Pharmacol 1982;60:1431–1435.
9.
Lemieux G, Vinay P, Robitaille P, Plante G, Lussier Y, Martin P: The effect of ketone bodies on renal ammoniagenesis. J Clin Invest 1971;50:1781–1791.
10.
Gluck S, Kelly S, Al-Awqati Q: The proton translocating ATPase responsible for urinary acidification. J Biol Chem 1982;257:9230–9233.
11.
Wingo CS, Armitage FE: Potassium transport in the kidney: Regulation and physiologic relevance of H+,K+-ATPase. Semin Nephrol 1993;13:213–224.
12.
Bengele HH, Schwartz JH, McNamara ER, Alexander EA: Chronic metabolic acidosis augments acidification along the inner medullary collecting duct. Am J Physiol 1986;250:F690–F694.
13.
Burnell JM, Teubner EJ, Simpson DP: Metabolic acidosis accompanying potassium deprivation. Am J Physiol 1974;227:329–333.
14.
Tannen RL: Effect of potassium on renal acidification and acid-base homeostasis. Semin Nephrol 1987;7:263–273.
15.
Wingo CS: Active proton secretion and potassium absorption in the rabbit outer medullary collecting duct. J Clin Invest 1989;84:361–365.
16.
Oh MS, Carroll HJ: Whole body acid-base balance; in Berlyne GM (ed): The Kidney Today, Selected Topics in Renal Science. Karger, Basel, 1992, vol 100, pp 89–104.
17.
Cohen RM, Feldman GM, Fernandez PC: The balance of acid, base and charge in health and disease. Kidney Int 1997;52:287–293.
18.
Lin P, Cheema-Dhadli S, Chayaraks S, Chen C-B, Gowrishankar M, Halperin ML: Physiological role of the potential alkali load in the diet of the rat for acid-base balance. Am J Physiol 1998;274:F1037–F1044.
19.
Packer RK, Curry CA, Brown KM: Urinary organic anion excretion in response to dietary acid and base loading. J Am Soc Nephrol 1995;5:1624–1629.
20.
Kamel KS, Ethier JH, Stinebaugh BJ, Schloeder FX, Halperin ML: The removal of an inorganic acid load in subjects with ketoacidosis of chronic fasting: The role of the kidney. Kidney Int 1990;38:507–511.
21.
Hood VL: pH regulation of endogenous acid production in subjects with chronic ketoacidosis. Am J Physiol 1985;249:F220–F226.
22.
Kamel KS, Lin S-H, Cheema-Dhadli S, Marliss EB, Halperin ML: Prolonged total fasting: A feast for the integrative physiologist. Kidney Int 1998;53:531–539.
23.
Lin S-H, Cheema-Dhadli S, Gowrishankar M, Marliss EB, Kamel KS, Halperin ML: Control of the excretion of potassium: Lessons from studies during prolonged fasting in human subjects. Am J Physiol 1997;273:F796–F800.
24.
Halperin ML, Kamel KS: Dynamic interactions between integrative physiology and molecular medicine: The key to understand the mechanism of action of aldosterone in the kidney. Can J Physiol Pharmacol 2000;78:587–594.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.